Literature DB >> 29198701

Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21.

Boqian Zhu1, Yaoyao Gong2, Gaoliang Yan1, Dong Wang1, Yong Qiao1, Qingjie Wang3, Bo Liu1, Jiantong Hou1, Ruifeng Li1, Chengchun Tang4.   

Abstract

Hypoxia-induced pulmonary hypertension is a life-threatening disease arising from a progressive increase in pulmonary vascular resistance, irreversible pulmonary vascular remodeling and resulting in right ventricular failure. Recent studies suggested that pulmonary artery smooth muscle cell proliferation and migration played an important role in the pathogenesis of hypoxia-induced pulmonary hypertension. However, the mechanisms of hypoxia-induced pulmonary hypertension are complicated and largely unclear. In this study, we discovered that lncRNA MEG3 was down-regulated in human pulmonary artery smooth muscle cell in hypoxia, and inhibition of MEG3 promoted the cell proliferation and cell migration in both normal and hypoxia condition. Further study demonstrated that MEG3 exerted its function via regulation of miR-21 expression in both normal and hypoxia condition. In addition, we displayed the modulation of PTEN by miR-21 and their role in hypoxia. Ultimately, our study illustrated that MEG3 exerts its role via miR-21/PTEN axis in human pulmonary artery smooth muscle cell under both normal and hypoxia conditions.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Competing endogenous RNA; Hypoxia-induced pulmonary hypertension; Pulmonary artery smooth muscle cells; lncRNA MEG3

Mesh:

Substances:

Year:  2017        PMID: 29198701     DOI: 10.1016/j.bbrc.2017.11.185

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension.

Authors:  Xiao-Wei Song; Lu-Lu Zou; Ling Cui; Song-Hua Li; Yong-Wen Qin; Xian-Xian Zhao; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

Review 2.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

Review 3.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

4.  Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.

Authors:  Tian-Tian Zhu; Rui-Li Sun; Ya-Ling Yin; Jin-Ping Quan; Ping Song; Jian Xu; Ming-Xiang Zhang; Peng Li
Journal:  Pflugers Arch       Date:  2018-10-23       Impact factor: 3.657

5.  SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.

Authors:  Yufeng Yao; Hui Li; Xinwen Da; Zuhan He; Bo Tang; Yong Li; Changqing Hu; Chengqi Xu; Qiuyun Chen; Qing K Wang
Journal:  Pulm Pharmacol Ther       Date:  2019-01-28       Impact factor: 3.410

6.  Identification of lncRNA-NR_104160 as a biomarker and construction of a lncRNA-related ceRNA network for essential hypertension.

Authors:  Wenjuan Peng; Han Cao; Kuo Liu; Chunyue Guo; Yanyan Sun; Han Qi; Zheng Liu; Yunyi Xie; Xiaohui Liu; Bingxiao Li; Ling Zhang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 7.  Long noncoding RNAs: emerging roles in pulmonary hypertension.

Authors:  Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Qin Luo; Zhihong Liu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

8.  Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.

Authors:  Yan Xing; Xiaodong Zheng; Yao Fu; Jing Qi; Minghui Li; Mingfei Ma; Shuang Wang; Shuzhen Li; Daling Zhu
Journal:  Mol Ther       Date:  2019-08-22       Impact factor: 11.454

Review 9.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

10.  Dysregulated lncRNA TUG1 in different pulmonary artery cells under hypoxia.

Authors:  Zhenchun Lv; Rong Jiang; Xiaoyi Hu; Qinhua Zhao; Yuanyuan Sun; Lan Wang; Jinling Li; Yuqing Miao; Wenhui Wu; Ping Yuan
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.